NograDerm is a late-stage pharmaceutical company focused on developing innovative treatments for immune-inflammatory mediated dermatological diseases and conditions.
Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise to identify, develop and commercialize best-in-class molecules acting on validated targets.